Strata Medical (SRTA) Long-Term Liabilities to Equity

Corporate emblem and logo of Strata Medical (SRTA)

The aviation medical platform Strata Critical Medical Inc (SRTA) operates within the norm, utilizing a streamlined patient transport model to directly convert fees into capital. Revenues are based on the conservatism of clinics purchasing mandatory consumables for the equipment. This chart reflects an asset value of 0.01, confirming the status of a brand that has implemented proven laser therapy methods for skin pathologies.

SRTA Strata Critical Medical Corp: Long-Term Debt to Capital in the range 07/04/2022 - 10/29/2026
Manufactured product of Strata Critical Medical Inc

For the fundamental screening of Strata Critical Medical Inc (SRTA), it is critical to monitor the long-term debt-to-equity ratio to promptly identify changes in financial stability. By analyzing the current level of long-term financial leverage, an investor assesses the proportion of loans with maturities exceeding one year, which, given the high dependence of Strata Critical Medical Inc (SRTA) on external contract equipment manufacturers, determines the risk of losing operational control.

Key competitors

Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|TNDM: Long-Term Debt to Capital|Long-Term Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Long-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|CARL - Long-Term Debt to Equity Ratio|RxSight Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital ClearPoint Neuro, Inc.|STXS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STIM|SGHT (Sight Sciences) - Long-Term Debt to Capital|Orchestra BioMed Inc. (OBIO) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ANIK|Long-Term Debt to Equity Ratio InspireMD Inc. NSPR|Long-Term Debt to Capital ZJYL (Jin Medical)|Long-Term Debt to Capital Vivani Medical Inc VANI|XTNT - Long-Term Debt to Equity|NMTC: Long-Term Debt to Equity|MODD (modular-medical.com) - Long-Term Debt to Equity Ratio|Myomo Inc - Long-Term Debt to Capital Coefficient|COCH (Envoy Medical, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital vivoslife.com VVOS|Long-Term Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Long-Term Indebtedness to Equity|Tenon Medical, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital